The proposed metabolic roles of BACE1 are supported by the common mechanisms and treatment targets between T2D, obesity, and AD, with the use of various antidiabetic and metabolic therapies in the treatment of AD showing promising results.160. This evidence concerns the gene BACE1 and obesity due to melanocortin 4 receptor deficiency.